Journal
DERMATOLOGIC CLINICS
Volume 21, Issue 2, Pages 291-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/S0733-8635(02)00094-3
Keywords
-
Categories
Ask authors/readers for more resources
Imiquimod (Aldara), an imidazoquinolone, is a topically applied immune response modifier. It has antiviral and antitumor effects as demonstrated in animal models and in clinical human use. Although the precise mechanism of action is unknown, imiquimod appears to exert therapeutic effects through the local induction of cytokines, which activate innate and cell-mediated acquired immunity. The approved indication for imiquimod is treatment of external genital warts; however, imiquimod has been used to successfully treat common, plantar, and flat warts, molluscum contagiosum, herpes simplex virus infections, and leishmaniasis. It might also help treat respiratory infection caused by parainfluenza.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available